Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Frontiers in Pharmacology|March 21, 2022
Predictive Simulations in Preclinical Oncology to Guide the Translation of BiologicsShujun Dong, Ian Nessler, Anna Kopp, et al.
Mabs|April 3, 2025
Maximizing activity and selectivity of antibody-mediated effector functions using antibody mixturesTiexin Wang, Alec A Desai, Greg M Thurber, et al.
The AAPS Journal|June 12, 2016
Multiscale Modeling of Antibody-Drug Conjugates: Connecting Tissue and Cellular Distribution to Whole Animal Pharmacokinetics and Potential Implications for EfficacyCornelius Cilliers, Hans Guo, Jianshan Liao, et al.
Molecular Oncology|January 6, 2026
Combining antibody conjugates with cytotoxic and immune-stimulating payloads maximizes anti-cancer activityTiexin Wang, Dong Jun Koo, Peter M Tessier, et al.
The AAPS Journal|January 17, 2020
An Agent-Based Systems Pharmacology Model of the Antibody-Drug Conjugate Kadcyla to Predict Efficacy of Different Dosing RegimensBruna Menezes, Cornelius Cilliers, Timothy Wessler, et al.
Chemistryopen|September 3, 2013
Efficient 18F-Labeling of Synthetic Exendin-4 Analogues for Imaging Beta CellsEdmund J Keliher, Thomas Reiner, Greg M Thurber, et al.
Methods in Enzymology|January 11, 2012
Practical theoretic guidance for the design of tumor-targeting agentsK Dane Wittrup, Greg M Thurber, Michael M Schmidt, et al.
Nature Reviews. Cancer|October 2, 2025
Unveiling the molecular and immunological drivers of antibody-drug conjugates in cancer treatmentAlfred Zippelius, Sara M Tolaney, Paolo Tarantino, et al.
Bioconjugate Chemistry|January 14, 2009
18F labeled nanoparticles for in vivo PET-CT imagingNeal K Devaraj, Edmund J Keliher, Greg M Thurber, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 2012
Reactive polymer enables efficient in vivo bioorthogonal chemistryNeal K Devaraj, Greg M Thurber, Edmund J Keliher, et al.
Pageof 7